हेपेटाइटिस बी?
परीक्षण कराएं !
अपने माता-पिता का परीक्षण कराएं!!
अपने दादा-दादी का का परीक्षण कराएं!
• हेपेटाइटिस बी वायरस (एचबीवी) मार सकता है।
• एक वैक्सीन है लेकिन अभी तक कोई इलाज नहीं है।
• अति उत्कृष्ट उपचार उपलब्ध है।
हेपेटाइटिस बी एक घातक जानलेवा रोग है
• हेपेटाइटिस बी वायरस (एचबीवी) के कारण हेपेटाइटिस बी एक गंभीर और लाइलाज बीमारी है, जो रक्त और शारीरिक तरल पदार्थ, और हेपटाइटिस बी पीड़ित मां से नवजात शिशु तक फैलती है। दुनिया भर में, 240 लाख
Clinical Care Options presents a new "Interactive Decision Support Tool" for Hepatitis B consultations to help determine whether and how to treat HBV patients, "Hep B Consult: US, European, and Asia-Pacific Guideline Recommendations on Whether and How to Treat HBV"
Downloading this tool is FREE but requires that you register with Clinical Care Options website:
https://www.clinicaloptions.com/hepatitis/programs/2019-hbv-management/idst/tool
Source: B
Friday, Jan 4, 2019
News Recap:
Hepatitis B Treatment, Viread, Approved in USA for Children Under 12
Hepatitis B in children is of particular concern, as the younger a person is when she/he contracts HBV, the greater likelihood of developing the chronic form of the disease. While HBV vaccination (primarily of users of IV drugs, or of infants born to HBV+ mothers) remains the greatest HBV-related public health challenge for Canada, we also should con...
Hepatitis B in children is of particular concern, as the younger a person is when she/he contracts HBV, the greater likelihood of developing the chronic form of the disease. While HBV vaccination (primarily of users of IV drugs, or of infants born to HBV+ mothers) remains the greatest HBV-related public health challenge for Canada, we also should consider the importance of treatment to our youngest victims of HBV. While this could involve a greater investm
Friday, Dec 7, 2018
News Recap:
Renally-Impaired Patients with Chronic Hepatitis B Virus Infection Find Success with Low Dose of TDF
A low dose of tenofovir disoproxil fumarate (TDF) may help to preserve renal function and maintain viral suppression in patients with chronic hepatitis B virus infection, even those with advanced liver disease, according to new research.
Join Us to Honour & Remember Our Friend Phil Wilkin
On Friday December 14,...
A low dose of tenofovir disoproxil fumarate (TDF) may help to preserve renal function and maintain viral suppression in patients with chronic hepatitis B virus infection, even those with advanced liver disease, according to new research.
TDF (Viread, Gilead) is currently approved for the treatment of chronic hepatitis B virus infection in adults and pediatric patients who are 12 years and older. Although the treatment is effective in inhibiting hepatitis
Friday, Nov 9, 2018
News Recap:
Gilead Presents Latest Data from Viral Hepatitis Research Programs at The Liver Meeting® 2018
Gilead Sciences announced results from studies investigating Epclusa in chronic HCV patients with severe renal impairment undergoing dialysis and Harvoni in pediatric HCV patients aged three to five years. As well there was data from Gilead’s HBV cure development program.
High Prevalence of Cirrhosis in Adults with Chronic...
